Royalty Pharma plc (RPRX) is trading at $60.33 down 0.43% over the past 24 hours. Its Galaxy Score is 54.5, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 6.6K engagements and 39 posts with 84% positive social sentiment.
AI summary: Biotechnology royalty company monetizing drug royalties. UBS upgrade and solid Q3 beat have sparked a rally, with social dip-buying underpinning further upside and a test of new highs.